NCT04401020 : Clinical Trial Detail - Cancer Knowledgebase (CKB)

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT04401020
Title	First-in-human Single Agent Study of SAR442257 in RRMM and RR-NHL
Recruitment	Active, not recruiting
Gender	both
Phase	Phase I
Variant Requirements	No
Sponsors	Sanofi
Indications	mycosis fungoides lymphoplasmacytic lymphoma mantle cell lymphoma diffuse large B-cell lymphoma follicular lymphoma marginal zone lymphoma non-Hodgkin lymphoma Sezary's disease chronic lymphocytic leukemia/small lymphocytic lymphoma multiple myeloma
Therapies	SAR442257
Age Groups:	adult \| senior
Covered Countries	USA \| NOR \| ESP \| CZE

NCT04401020
Clinical Trial Detail